<?xml version="1.0" encoding="UTF-8"?>
<p>A more recent case series of individuals with rheumatic disease on hydroxychloroquine did not reveal any difference in the development of COVID-19 [
 <xref rid="B16" ref-type="bibr">16</xref>]. A randomized trial of postexposure prophylaxis using hydroxychloroquine did not reveal any protective effect of developing illness compatible with COVID-19 [
 <xref rid="B17" ref-type="bibr">17</xref>].
</p>
